Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity-Reference-Cited by-同舟云学术

Interleukin-6 blockade abrogates immunotherapy toxicity and promotes tumor immunity

Published:2022-05 Issue:5 Volume:40 Page:509-523.e6
ISSN:1535-6108
Container-title:Cancer Cell
language:en
Short-container-title:Cancer Cell

Author:

Hailemichael Yared,Johnson Daniel H.,Abdel-Wahab Noha,Foo Wai Chin^ORCID,Bentebibel Salah-Eddine,Daher May,Haymaker Cara,Wani Khalida,Saberian Chantal,Ogata Dai^ORCID,Kim Sang T.,Nurieva Roza,Lazar Alexander J.,Abu-Sbeih Hamzah,Fa'ak Faisal,Mathew Antony,Wang Yinghong,Falohun Adewunmi,Trinh Van,Zobniw Chrystia,Spillson Christine,Burks Jared K.,Awiwi Muhammad,Elsayes Khaled,Soto Luisa Solis,Melendez Brenda D.,Davies Michael A.,Wargo Jennifer,Curry Jonathan,Yee Cassian,Lizee Gregory,Singh Shalini,Sharma Padmanee,Allison James P.,Hwu Patrick,Ekmekcioglu Suhendan,Diab Adi

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference47 articles.

1. Encephalitogenic T cells that stably express both T-bet and RORγt consistently produce IFNγ but have a spectrum of IL-17 profiles;Abromson-Leeman;J. Neuroimmunol.,2009

2. Resumption of immune checkpoint inhibitor therapy after immune-mediated colitis;Abu-Sbeih;J. Clin. Oncol.,2019

3. Immune dysregulation in cancer patients undergoing immune checkpoint inhibitor treatment and potential predictive strategies for future clinical practice;Anderson;Front. Oncol.,2018

4. The differentiation and plasticity of Tc17 cells are regulated by CTLA-4-mediated effects on STATs;Arra;Oncoimmunology,2017

5. Immunological characteristics of colitis associated with anti-CTLA-4 antibody therapy;Bamias;Cancer Invest.,2017

Cited by 164 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling the contribution of tumor-associated macrophages in driving epithelial-mesenchymal transition: a review of mechanisms and therapeutic Strategies;Frontiers in Pharmacology;2024-09-02

2. IL-12-mediated toxicity from localized oncolytic virotherapy can be reduced using systemic TNF blockade;Molecular Therapy: Oncology;2024-09

3. Polypropylene sulfide methotrexate nanoparticles target the synovial lymphatic system to restore immune tolerance in rheumatoid arthritis;International Journal of Pharmaceutics;2024-09

4. A targetable type III immune response with increase of IL-17A expressing CD4+ T cells is associated with immunotherapy-induced toxicity in melanoma;Nature Cancer;2024-08-29

5. Targeting IL-17A to combat immune-related adverse events;Nature Cancer;2024-08-29